Key Takeaways
- A study led by Professor Matthias Betz evaluated 11 healthy volunteers to observe energy expenditure under cold exposure and fenoterol treatment.
- Although fenoterol spurred substantial energy burning, scans showed it did not activate brown fat in the way cold exposure does.
- Professor Matthias Betz stated that “Our study shows that an increase in energy expenditure does not automatically mean that brown fat has been activated.”
Unexpected metabolic findings in clinical trial
In a promising exploration of how the human body consumes energy, medical researchers have found that stimulating certain cellular receptors can significantly elevate calorie burning. A clinical study led by Professor Matthias Betz from the University of Basel and University Hospital Basel examined how the drug fenoterol impacts metabolic rates in humans, offering surprising insights into energy balance.
Scientists have long sought ways to safely increase energy expenditure, particularly as a complementary strategy to current weight management therapies that primarily curb appetite. “Ideally, we could combine a reduction in appetite with an increase in energy expenditure,” explained Betz. “But first we need a better understanding of how brown adipose tissue is regulated.”
Comparing cold exposure and beta2 stimulation
Brown adipose tissue, commonly known as brown fat, naturally burns calories to generate warmth during cold exposure. Individuals who exhibit naturally active brown fat typically display leaner bodies and favorable metabolic health. To discover whether pharmacological methods could replicate this natural thermal response, the team evaluated 11 healthy volunteers under two conditions: mild cold exposure and fenoterol administration, which stimulates beta2 adrenergic receptors.
During both interventions, researchers monitored overall energy expenditure and evaluated brown fat activity through PET/CT imaging scans. While cold exposure prompted brown fat to absorb large amounts of glucose for fuel, the drug produced an intriguing departure from expectations.
“We were surprised that energy expenditure increased strongly with fenoterol even though we could not detect a comparable activation of brown fat,” Betz noted. “Our study shows that an increase in energy expenditure does not automatically mean that brown fat has been activated.”
Exploring alternative pathways for calorie burning
Because the PET/CT scans did not demonstrate standard glucose uptake in brown fat after taking the medication, the team determined that the additional energy was being burned through alternative physiological pathways. Researchers suggest skeletal muscle or white adipose tissue may have played a role in consuming the extra calories during the trial.
Furthermore, human tissue examinations indicate that achieving full brown fat activation might require multiple biological signals acting simultaneously rather than a single receptor trigger. While fenoterol did not ignite brown fat in the anticipated manner, uncovering an alternative avenue for boosting energy consumption provides valuable guidance for developing future therapies designed to support human metabolic health.
